These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 14378478)

  • 41. Experience with the intrauterine transfusion in severe rhesus erythroblastosis.
    Hofmann D; Holländer HJ; Mast H; Quakernack K; Schellong G
    Geburtshilfe Frauenheilkd; 1971 Sep; 31(9):797-814. PubMed ID: 4999762
    [No Abstract]   [Full Text] [Related]  

  • 42. [Prenatal prognosis of hemolytic disease of newborn. II. Prognosits value of maternal antibodies].
    POLACEK K
    Cesk Gynekol; 1961 Apr; 26():212-9. PubMed ID: 13736656
    [No Abstract]   [Full Text] [Related]  

  • 43. Management of pregnancies complicated by anti-E alloimmunization.
    Joy SD; Rossi KQ; Krugh D; O'Shaughnessy RW
    Obstet Gynecol; 2005 Jan; 105(1):24-8. PubMed ID: 15625137
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Molecular determination of RHD zygosity: predicting risk of hemolytic disease of the fetus and newborn related to anti-D.
    Pirelli KJ; Pietz BC; Johnson ST; Pinder HL; Bellissimo DB
    Prenat Diagn; 2010 Dec; 30(12-13):1207-12. PubMed ID: 21072752
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Towards the conquest of RH hemolytic disease.
    Merchant RH
    Indian Pediatr; 1993 Jun; 30(6):835-8. PubMed ID: 8132277
    [No Abstract]   [Full Text] [Related]  

  • 46. Diagnosis and treatment of severe hemolytic disease of the fetus and newborn: a 10-year nationwide retrospective study.
    Sainio S; Nupponen I; Kuosmanen M; Aitokallio-Tallberg A; Ekholm E; Halmesmäki E; Orden MR; Palo P; Raudaskoski T; Tekay A; Tuimala J; Uotila J; Stefanovic V
    Acta Obstet Gynecol Scand; 2015 Apr; 94(4):383-90. PubMed ID: 25603954
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Treatment of fetal hemolytic disease by hemosorption].
    Sergienko NS; Malinovskaia SIa; Sichinava LG
    Akush Ginekol (Mosk); 1989 Sep; (9):56-9. PubMed ID: 2512819
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Hemolytic disease of the fetus: a plea for restraint.
    Bowman JM; Pollock J; Menticoglou S; Harman CR; Manning FA
    Obstet Gynecol; 1993 Mar; 81(3):478-80. PubMed ID: 8489626
    [No Abstract]   [Full Text] [Related]  

  • 49. Hemolytic disease of the fetus: a plea for restraint.
    Weiner CP
    Obstet Gynecol; 1993 Mar; 81(3):478-9; author reply 479-80. PubMed ID: 8437810
    [No Abstract]   [Full Text] [Related]  

  • 50. Severe hemolytic disease of the fetus and the newborn associated with anti-Vw (Vw).
    Moncharmont P; Buclet D; Trouilloud C; Peyrard T; Rigal D
    J Matern Fetal Neonatal Med; 2010 Sep; 23(9):1066-8. PubMed ID: 19883266
    [No Abstract]   [Full Text] [Related]  

  • 51. [Hemolytic diseases of the newborn in Japan].
    Shirakawa M
    Nihon Sanka Fujinka Gakkai Zasshi; 1971 Aug; 23(8):730-40. PubMed ID: 4999292
    [No Abstract]   [Full Text] [Related]  

  • 52. [Remote after-effects of hemolytic diseases in newborn, caused by the ABO- and Rh-incompatibility in the blood of mother and fetus].
    Nersisian VM
    Zh Eksp Klin Med; 1969; 9(5):82-5. PubMed ID: 4988140
    [No Abstract]   [Full Text] [Related]  

  • 53. Delayed anemia in erythroblastosis fetalis.
    Strand C; Polesky HF
    Minn Med; 1972 May; 55(5):439-41. PubMed ID: 4624082
    [No Abstract]   [Full Text] [Related]  

  • 54. [Prenatal diagnosis and therapy of hemolytic disease of the newborn].
    Fischer K; Poschmann A; Hellwege HH; Kitschke HJ; Carstensen M; Sprotte C; Schreer I
    Monatsschr Kinderheilkd; 1985 Mar; 133(3):167-70. PubMed ID: 4010672
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Glutathione peroxidase deficiency in the erythrocytes in the newborn with hemolytic anemia].
    Boivin P
    Minerva Pediatr; 1968 Dec; 20(51):2692-5. PubMed ID: 5753806
    [No Abstract]   [Full Text] [Related]  

  • 56. [Practical difficulties in the Rh prevention].
    Martínez M; Fernández P; Lozano G; Flores F; Garrido G
    Acta Obstet Ginecol Hisp Lusit; 1971 Feb; 19(1):45-51. PubMed ID: 5088163
    [No Abstract]   [Full Text] [Related]  

  • 57. [Prevention of fetal erythroblastosis with anti-D immunoglobulin].
    Rasteński J; Gryglicka M
    Acta Haematol Pol; 1988; 19(3-4):239-41. PubMed ID: 3150900
    [No Abstract]   [Full Text] [Related]  

  • 58. [Proceedings: Obstetrical prophylaxis].
    Centaro A; Rondinelli M
    Minerva Pediatr; 1973 Oct; 25(36):1497-508. PubMed ID: 4797723
    [No Abstract]   [Full Text] [Related]  

  • 59. Experiences of a "Rhesus" committee.
    Heron HJ; Howie JB; McGeorge M; Tolley MA
    N Z Med J; 1966 Apr; 65(404):231-5. PubMed ID: 5220691
    [No Abstract]   [Full Text] [Related]  

  • 60. Fatal hemolytic disease of the fetus and newborn possibly due to anti-Jr.
    Arriaga F; Gomez I; Linares MD; Gascon A; Carpio N; Perales A
    Transfusion; 2009 Apr; 49(4):813. PubMed ID: 19335378
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.